Limitless Possibilities
Through Exquisite Control
At IFM Therapeutics, we work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response and an essential component of immune function.
Regulating
Immune Response
Serious diseases can result if the immune system consistently under- or over-responds. Our first-in-class medicines precisely control immune responses in patients with inflammatory or autoimmune disorders, and enhance responses in patients with cancer.
A Leading Portfolio of
First-in-Class Small Molecules
We are working with urgency to develop novel drugs that meet the needs of patients with inflammatory disorders and cancer.
Recent Updates
May
23
Feb
23
RT @GlobeRobW: Pharma giant $bmy forks out $300m to snatch #CambMA biotech @IFMThera, in bid to boost its #Cancer drug pipeline.
https://t…